<?xml version="1.0" encoding="UTF-8"?>
<p id="Par30">Using a computer-generated sequence of numbers, patients in group S will be randomly assigned to receive either conventional therapy for septic shock alone (CT) as per the Surviving Sepsis Campaign guidelines (S1) or standard therapy plus extracorporeal hemoperfusion therapy (HCT) with polymyxin B-immobilized polystyrene-derived fibers to remove endotoxins from the blood (S2) [
 <xref ref-type="bibr" rid="CR21">21</xref>]. Healthy volunteers (group H) will be recruited from among staff members of the University Hospital Foggia (Figs. 
 <xref rid="Fig1" ref-type="fig">1</xref> and 
 <xref rid="Fig2" ref-type="fig">2</xref>).
</p>
